West Lafayette, IN, United States of America

Yingjuan June Lu

This inventor holds 9 USPTO granted patents and 15 published patent applications and 1 EPO patent. Top assignees: Endocyte, Inc., Purdue Research Foundation, Seattle Children's Hospital. Active years: 2006-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yingjuan June Lu. Retrieved from https://idiyas.com/inventor/yingjuan-june-lu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 15)

% Patents Active = 88.9

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 96(Granted Patents)

Company Filing History:

Purdue Research Foundation

patents

3 out of 89

Seattle Children's Hospital

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12269862 - Methods of use for CAR T cells (2025-04-08),

2. 12240870 - Sequencing method for CAR T cell therapy (2025-03-04),

3. 11850262 - Compositions and methods for CAR T cell therapy (2023-12-26),

4. 11779602 - Methods of use for CAR T cells (2023-10-10),

5. 11759480 - Compositions and methods for CAR T cell therapy (2023-09-19),

6. 10500204 - Vitamin receptor drug delivery conjugates for treating inflammation (2019-12-10),

7. 9877965 - Vitamin receptor drug delivery conjugates for treating inflammation (2018-01-30),

8. 8105608 - Method of treatment using ligand-immunogen conjugates (2012-01-31),

9. 7033594 - Method of treatment using ligand-immunogen conjugates (2006-04-25),

Title: Innovations by Yingjuan June Lu in CAR T Cell Therapy

Introduction

Yingjuan June Lu is an accomplished inventor based in West Lafayette, IN, with a remarkable portfolio of eight patents. Her innovative work focuses on enhancing cancer treatment methodologies, particularly through advancements in CAR T cell therapy.

Latest Patents

Among her latest patents is a sequencing method for CAR T cell therapy, which details a new approach to treating cancer patients by administering a composition that includes CAR T cells. This method emphasizes the role of small molecules linked to targeting moieties via a linker, paving the way for more effective treatment regimens. Additionally, her patent on compositions and methods for CAR T cell therapy further expands upon these concepts, demonstrating her commitment to improving cancer treatment through targeted therapies.

Career Highlights

Yingjuan Lu's career has seen her associated with prestigious organizations such as the Purdue Research Foundation and Endocyte, Inc. Her contributions to the field of cancer treatment have been instrumental in pushing the boundaries of current therapeutic options.

Collaborations

Throughout her career, Yingjuan June Lu has collaborated with notable colleagues, including Philip Stewart Low and Christopher Paul Leamon. Their combined expertise has fostered innovative solutions and advancements in the field of CAR T cell therapy.

Conclusion

Yingjuan June Lu's innovative spirit and dedication to her work have significantly impacted cancer treatment methodologies. Her patents reflect a forward-thinking approach that could potentially change the landscape of therapy for cancer patients, showcasing the importance of innovation in medical science.

Profile summary based on public USPTO records.